Abeona Therapeutics Correlations
ABEO Stock | USD 5.15 0.01 0.19% |
The current 90-days correlation between Abeona Therapeutics and Checkpoint Therapeutics is 0.1 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Abeona Therapeutics Correlation With Market
Modest diversification
The correlation between Abeona Therapeutics and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Abeona |
Moving together with Abeona Stock
Moving against Abeona Stock
0.51 | CVX | Chevron Corp | PairCorr |
0.45 | JNJ | Johnson Johnson | PairCorr |
0.42 | XOM | Exxon Mobil Corp | PairCorr |
0.41 | MMM | 3M Company | PairCorr |
0.34 | T | ATT Inc Earnings Call Today | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Abeona Stock performing well and Abeona Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Abeona Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RVPH | 5.07 | (0.78) | 0.00 | (0.27) | 0.00 | 11.05 | 39.67 | |||
ATHA | 3.64 | (0.71) | 0.00 | (1.15) | 0.00 | 6.45 | 21.64 | |||
FBIO | 2.67 | (0.11) | 0.00 | (0.65) | 0.00 | 5.19 | 22.19 | |||
ACAD | 1.96 | 0.05 | 0.00 | (0.02) | 0.00 | 4.29 | 17.29 | |||
CABA | 4.31 | (0.49) | 0.00 | (0.43) | 0.00 | 8.87 | 26.78 | |||
EVFMD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CALA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AFMD | 3.14 | (1.06) | 0.00 | (0.64) | 0.00 | 5.10 | 29.11 | |||
CKPT | 4.74 | 0.33 | 0.11 | (0.22) | 4.13 | 10.94 | 61.63 | |||
ADAP | 3.10 | (0.80) | 0.00 | (1.08) | 0.00 | 4.84 | 52.59 |
Abeona Therapeutics Corporate Management
Joseph Vazzano | Chief Officer | Profile | |
Dmitriy MD | Chief Officer | Profile | |
Brian Kevany | CTO VP | Profile | |
Carl Denny | Senior Affairs | Profile | |
Alison Hardgrove | Vice Resources | Profile | |
Scott Santiamo | Director Communications | Profile |